awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38668352-479FF6CE-0EFE-4BDC-9E83-431D71D497BC
Q38668352-479FF6CE-0EFE-4BDC-9E83-431D71D497BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38668352-479FF6CE-0EFE-4BDC-9E83-431D71D497BC
Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.
P2860
Q38668352-479FF6CE-0EFE-4BDC-9E83-431D71D497BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38668352-479FF6CE-0EFE-4BDC-9E83-431D71D497BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a2095ab65e2ee2f093c66dc8cc6f91bb4c93e315
P2860
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.